» Articles » PMID: 16804073

Leptin Suppresses Stearoyl-CoA Desaturase 1 by Mechanisms Independent of Insulin and Sterol Regulatory Element-binding Protein-1c

Overview
Journal Diabetes
Specialty Endocrinology
Date 2006 Jun 29
PMID 16804073
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Stearoyl-CoA desaturase (SCD)1 catalyzes the rate-limiting reaction of monounsaturated fatty acid (MUFA) synthesis and plays an important role in the development of obesity. SCD1 is suppressed by leptin but induced by insulin. We have used animal models to dissect the effects of these hormones on SCD1. In the first model, leptin-deficient ob/ob mice were treated with either leptin alone or with both leptin and insulin to prevent the leptin-mediated fall in insulin. In the second model, mice with a liver-specific knockout of the insulin receptor (LIRKO) and their littermate controls (LOXs) were treated with leptin. As expected, leptin decreased SCD1 transcript, protein, and activity by >60% in ob/ob and LOX mice. However, the effects of leptin were not diminished by the continued presence of hyperinsulinemia in ob/ob mice treated with both leptin and insulin or the absence of insulin signaling in LIRKO mice. Furthermore, genetic knockout of sterol regulatory element-binding protein (SREBP)-1c, the lipogenic transcription factor that mediates the effects of insulin on SCD1, also had no effect on the ability of leptin to decrease either SCD1 transcript or activity. Thus, the effect of leptin on SCD1 in liver is independent of insulin and SREBP-1c, and leptin, rather than insulin, is the major regulator of hepatic MUFA synthesis in obesity-linked diabetes.

Citing Articles

An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors.

Kirad S, Puri S, Deepa P, Sankaranarayanan M RSC Adv. 2024; 14(41):30487-30517.

PMID: 39318456 PMC: 11421311. DOI: 10.1039/d4ra06237j.


Associations of fatty acids composition and estimated desaturase activities in erythrocyte phospholipids with biochemical and clinical indicators of cardiometabolic risk in non-diabetic Serbian women: the role of level of adiposity.

Sarac I, Debeljak-Martacic J, Takic M, Stevanovic V, Milesevic J, Zekovic M Front Nutr. 2023; 10:1065578.

PMID: 37545582 PMC: 10397414. DOI: 10.3389/fnut.2023.1065578.


Targeting Stearoyl-CoA Desaturase in Solid Tumors.

Kubota C, Espenshade P Cancer Res. 2022; 82(9):1682-1688.

PMID: 35294526 PMC: 9064960. DOI: 10.1158/0008-5472.CAN-21-4044.


Integrated Liver and Plasma Proteomics in Obese Mice Reveals Complex Metabolic Regulation.

Stocks B, Gonzalez-Franquesa A, Borg M, Bjornholm M, Niu L, Zierath J Mol Cell Proteomics. 2022; 21(3):100207.

PMID: 35093608 PMC: 8928073. DOI: 10.1016/j.mcpro.2022.100207.


Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.

Mrazikova L, Neprasova B, Mengr A, Popelova A, Strnadova V, Hola L Front Pharmacol. 2021; 12:779962.

PMID: 34867411 PMC: 8637538. DOI: 10.3389/fphar.2021.779962.